Skip to content
← Full study record

NCT01047345 · BASELINE

Baseline characteristics

A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) · Source last updated 2018-11-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      618
    2. group Id
      BG001
      value
      306
    3. group Id
      BG002
      value
      924
    units
    Participants
groups
  1. description
    Blinded 9vHPV vaccine (V503) 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Base Study. Participants will not continue to the Extension Study.
    id
    BG000
    title
    9vHPV Vaccine - Base Study
  2. description
    Blinded 0.5 mL intramuscular injection of saline placebo at Day 1, Month 2, and Month 6 of the Base Study. After completion of the Base Study, participants will be eligible to receive open-label 9vHPV 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Extension Study.
    id
    BG001
    title
    Placebo - Base Study
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          122
        2. group Id
          BG001
          value
          60
        3. group Id
          BG002
          value
          182
      title
      12 to 15 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          496
        2. group Id
          BG001
          value
          246
        3. group Id
          BG002
          value
          742
      title
      16 to 26 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          618
        2. group Id
          BG001
          value
          306
        3. group Id
          BG002
          value
          924
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      618
    2. group Id
      BG001
      value
      306
    3. group Id
      BG002
      value
      924
    units
    Participants
groups
  1. description
    Blinded 9vHPV vaccine (V503) 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Base Study. Participants will not continue to the Extension Study.
    id
    BG000
    title
    9vHPV Vaccine - Base Study
  2. description
    Blinded 0.5 mL intramuscular injection of saline placebo at Day 1, Month 2, and Month 6 of the Base Study. After completion of the Base Study, participants will be eligible to receive open-label 9vHPV 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Extension Study.
    id
    BG001
    title
    Placebo - Base Study
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          122
        2. group Id
          BG001
          value
          60
        3. group Id
          BG002
          value
          182
      title
      12 to 15 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          496
        2. group Id
          BG001
          value
          246
        3. group Id
          BG002
          value
          742
      title
      16 to 26 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          618
        2. group Id
          BG001
          value
          306
        3. group Id
          BG002
          value
          924
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice